Skip to main content

Mesoblast Ltd

MESO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001345099

No open-market purchases or sales by Mesoblast Ltd insiders were filed in the last 90 days; 72 institutions reported holding it in 13F filings for Q2 2026, worth $53.3M in total; no superinvestor holds it.

Other share classesMEOBF

Q4 2022 vs. Q3 2022

How the institutions holding Mesoblast Ltd changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of MESO: Q3 2022 compared with Q4 2022
MeasureQ3 2022Of which not filed for Q4 2022Q4 2022Change
Holders37342+8
Shares3.84M151.0K2.68M−1.00M (−27.2%)
Value$10.3M$384.0K$7.89M−$2.03M (−20.5%)

3 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (11)

Institutions that held Mesoblast Ltd at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to MESO in Q4 2022
InstitutionSharesValue% of portfolio
Citadel Advisors LLC137,531$400.2K0.00%
Millennium Management LLC118,158$344.0K0.00%
Jane Street Group, LLC62,965$186.7K0.00%
Old Mission Capital LLC49,952$145.4K0.01%
Goldman Sachs Group Inc36,408$105.9K0.00%
Marshall Wace, LLP29,173$84.9K0.00%
Tobias Financial Advisors, Inc.20,000$58.2K0.02%
Chapin Davis, Inc.15,000$43.6K0.03%
Belpointe Asset Management LLC4,120$12.0K0.00%
Belvedere Trading LLC1,782$5.19K0.00%
BNP Paribas Arbitrage, SA119$3460.00%

Sold out (3)

Institutions that held Mesoblast Ltd at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of MESO in Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Balyasny Asset Management LLC59,720$152.0K
US Bancorp566$1.00K
Citigroup Inc96$0

Not filed for Q4 2022 yet (3)

Institutions that held Mesoblast Ltd at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding MESO in Q3 2022 that haven't filed for Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Ronit Capital LLP150,000$382.0K
Covington Capital Management500$1.00K
Wipfli Financial Advisors LLC,541$1.00K